MedTrace Logo

Antibiotic Prescription for Children With Acute Upper Respiratory Tract Infections in Assiut District

NCT04127682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2022-11-08

No results posted yet for this study

Summary

Antibiotics are one of the most commonly prescribed drugs in pediatric care all over the world. Over prescription of antibiotics is a major public health problem and the most important factor in the emergence of antibiotic resistance. It is important to study physicians' antibiotic prescribing behavior to understand its determinant and for further planning of appropriate interventions to optimize antibiotic prescription.

Conditions

  • Antibiotic Side Effect

Interventions

OTHER

Antibiotic KAP questionnaire

• Self-administered questionnaire will be used and containing following Physician information (age, sex, place of work, specialty, years of experience, place of work, and post graduate studies and trainings), Practice information (number of days for outpatient's practice/week, average number of patients /day and average percentage of children with ARIs/day), Antibiotic prescription practice (using of guidelines and causes of prescribing antibiotics in acute URIs), Knowledge about antibiotic resistance and attendance of any conference or educational activities concerned with antibiotic use during the last year, Attitude as regard antibiotic prescription.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mahmoud A Abd El Aty · Public Health Department, Faculty of Medicine, Assiut University

  • Sabra M Ahmed · Public Health Department, Faculty of Medicine, Assiut University

  • Ghada O El-Sadafi · Pediatrics department, Faculty of Medicine, Assiut University

  • Amira F El-Gazzar · Public Health Department, Faculty of Medicine, Assiut University

  • Mariam T Amin · Public Health Department, Faculty of Medicine, Assiut University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-07-30
Completion
2022-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04127682 on ClinicalTrials.gov